These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 33238084)
1. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. Reinstein SA; Cosgrove J; Malekshahi T; Deligiannidis KM J Clin Psychiatry; 2020 Nov; 81(6):. PubMed ID: 33238084 [No Abstract] [Full Text] [Related]
2. Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics. Keith SJ; Kane JM; Turner M; Conley RR; Nasrallah HA J Clin Psychiatry; 2004 Jan; 65(1):120-31. PubMed ID: 14744181 [No Abstract] [Full Text] [Related]
3. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia. Dursun S J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780 [No Abstract] [Full Text] [Related]
4. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758 [TBL] [Abstract][Full Text] [Related]
5. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. arap Mengech HN; Wazome EG East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736 [No Abstract] [Full Text] [Related]
6. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention. Agid O; Foussias G; Remington G Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707 [TBL] [Abstract][Full Text] [Related]
7. Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Masand PS; Gupta S Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433 [TBL] [Abstract][Full Text] [Related]
8. Atypical Antipsychotics for Schizophrenia and/or Bipolar Disorder in Pregnancy: Current Recommendations and Updates in the NICE Guidelines. Poo SX; Agius M Psychiatr Danub; 2015 Sep; 27 Suppl 1():S255-60. PubMed ID: 26417775 [TBL] [Abstract][Full Text] [Related]
9. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Keith S Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665 [TBL] [Abstract][Full Text] [Related]
10. Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic. Tohen M; Goldberg JF; Hassoun Y; Sureddi S J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32558403 [TBL] [Abstract][Full Text] [Related]
11. Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis. Prajapati AR; Wilson J; Song F; Maidment I Bipolar Disord; 2018 Dec; 20(8):687-696. PubMed ID: 30417552 [TBL] [Abstract][Full Text] [Related]
12. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. Park EJ; Amatya S; Kim MS; Park JH; Seol E; Lee H; Shin YH; Na DH Arch Pharm Res; 2013 Jun; 36(6):651-9. PubMed ID: 23543652 [TBL] [Abstract][Full Text] [Related]
13. A critical appraisal of long acting injectable antipsychotics: Translating research to clinics. Sreeraj VS; Shivakumar V; Rao NP; Venkatasubramanian G Asian J Psychiatr; 2017 Aug; 28():57-64. PubMed ID: 28784398 [TBL] [Abstract][Full Text] [Related]
14. A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects. Tosato S; Albert U; Tomassi S; Iasevoli F; Carmassi C; Ferrari S; Nanni MG; Nivoli A; Volpe U; Atti AR; Fiorillo A J Clin Psychiatry; 2017 May; 78(5):e477-e489. PubMed ID: 28297592 [TBL] [Abstract][Full Text] [Related]
15. Olanzapine: a review of rapid and long-acting parenteral formulations. Owen RT Drugs Today (Barc); 2010 Mar; 46(3):173-81. PubMed ID: 20467591 [TBL] [Abstract][Full Text] [Related]
16. All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics. Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS Curr Med Res Opin; 2018 Jan; 34(1):41-47. PubMed ID: 29057674 [TBL] [Abstract][Full Text] [Related]
17. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]. Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464 [TBL] [Abstract][Full Text] [Related]
18. The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia. Joshi K; Mao L; Biondi DM; Millet R BMC Psychiatry; 2018 Jan; 18(1):24. PubMed ID: 29378547 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and dosing of long-acting injectable antipsychotics. Kim DD; Barr AM; Rafizadeh R; Procyshyn RM J Psychiatry Neurosci; 2021 Sep; 46(5):E516-E517. PubMed ID: 34467748 [No Abstract] [Full Text] [Related]
20. Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care. Galbally M; Snellen M; Walker S; Permezel M Aust N Z J Psychiatry; 2010 Feb; 44(2):99-108. PubMed ID: 20113298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]